The parents of a child born with a cleft lip and palate linked to the mother’s use of the anti-seizure drug Topamax during pregnancy have received a $3 million jury award in a failure-to-warn case in Philadelphia.

The jury’s award March 7 in Anderson v. Janssen Pharmaceuticals marks the third Topamax-related verdict issued against Janssen Pharmaceuticals, the Johnson & Johnson subsidiary that manufactures the drug.